NCT05738187
- Conditions
- Head and Neck Neoplasms, Local Cryotherapy Treatment, Neoplasms, +2 more
- Locations
-
- Hôpitaux Universitaires de Strasbourg Strasbourg, France
Clinical trial condition
Recurrent Head and Neck Cancer
Explore clinical trials studying Recurrent Head and Neck Cancer. Study availability and eligibility vary by location and protocol.
17 public trials
5 recruiting studies
Recurrent Head and Neck Cancer trial results
NCT06239220
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +11 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +14 more
- Locations
-
- California Research Institute Los Angeles, California, United States
- UCLA Cancer Care Los Angeles, California, United States
- Stanford Cancer Institute Palo Alto, California, United States
- Yale University New Haven, Connecticut, United States
NCT07501650
- Conditions
- Disease Attributes, Head and Neck Cancer, Head and Neck Neoplasms, +8 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
- Locations
-
- Ospedale Oncologico "A. Businco" ARNAS BROTSU Cagliari, CAGLIARI, Italy
- Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-S. Marco Catania, CATANIA, Italy
- Azienda Ospedaliero-Universitaria Careggi Florence, FIRENZE, Italy
- Fondazione IRCCS Istituto Nazionale dei Tumori (INT) di Milano Milan, Milano, Italy
Active, not recruiting
Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
NCT06790966
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HPV Positive Oropharyngeal Squamous Cell Carcinoma, +11 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Marin Cancer Care Greenbrae, California, United States
- University of California, Orange Orange, California, United States
- Yale University New Haven, Connecticut, United States
Active, not recruiting
Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma
NCT05980000
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +11 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT03691714
- Conditions
- Head and Neck Cancer, Head and Neck Neoplasms, Metastatic Cancer, +7 more
- Locations
-
- UC Health Cincinnati, Ohio, United States
NCT04260126
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HPV Positive Oropharyngeal Squamous Cell Carcinoma, +9 more
- Locations
-
- Marin Cancer Center Greenbrae, California, United States
- University of California San Francisco San Francisco, California, United States
- Mayo Clinic Jacksonville, Florida, United States
- Cleveland Clinic Florida Weston, Florida, United States
NCT02358031
- Conditions
- Head and Neck Neoplasms, Metastatic Head and Neck Cancer, Neoplasms, +3 more
- Locations
-
Not specified